SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-009243
Filing Date
2020-04-15
Accepted
2020-04-15 14:01:04
Documents
7
Period of Report
2020-04-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea120689-8k_aikidopharma.htm 8-K 28757
2 FORM OF PLACEMENT AGENT'S WARRANT ea120689ex4-1_aikidopharma.htm EX-4.1 98017
3 OPINION OF ELLENOFF GROSSMAN & SCHOLE LLP ea120689ex5-1_aikidopharma.htm EX-5.1 7126
4 FORM OF SECURITIES PURCHASE AGREEMENT ea120689ex10-1_aikidopharma.htm EX-10.1 174353
5 PRESS RELEASE,DATED APRIL 15, 2020 ea120689ex99-1_aikidopharma.htm EX-99.1 9587
6 GRAPHIC ex5-1_001.jpg GRAPHIC 11461
7 GRAPHIC ex99-1_001.jpg GRAPHIC 18653
  Complete submission text file 0001213900-20-009243.txt   361103
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
Aikido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 20793307
SIC: 8731 Services-Commercial Physical & Biological Research